Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Venereal Diseases 2017

About Conference

ConferenceSeries Ltd invites all the participants from all over the world to attend ‘2nd International Congress on Venereal Diseases’ during November 13-14, 2017 in Las Vegas, Nevada, USA which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

In line with the of 2nd International Congress on Venereal Diseases, addressing the most recent advances across the spectrum of Genital research from basic sciences to public health, Conference Highlights of various Venereal Diseases, Advances in Venereal Diseases, Vaccines and Vaccination, Public Awareness.

ConferenceSeries Ltd Organizes 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50,000 eminent personalities, reputed scientists as editorial board members. 

Featuring 2 days of Scientific workshop, Special sessions, Speaker & Poster session, Industrial Expo. 300+ attendees from all over the world. 

Why to attend???

As mentioned earlier, Venereal Disease research, involves people from various disciplines and people form such various fields do not always get a chance to meet and discuss the current developments in their respective areas. Venereal Diseases seek to bring all such people together and thereby provide them a platform with which to discuss and exchange ideas with one another. The Venereal disease conference is set to be graced by World-renowned speakers who will shed light on the most recent techniques, tactics, and the newest updates in Venereal Diseases

Target Audience

·         Virologists

·         Immunologists

·         Microbiologists

·         Epidemiologists

·         Doctors

·         Public health planners

·         Primary Care Practitioners (Family Practice, Internal Medicine, General Practice)

·         Physician Assistants

·         Nurse Practitioners

·         Laboratory Professionals and

·         Healthcare professionals interested in screening, treating and counseling patients regarding infectious diseases.

Scientific Sessions

In line with the of 2nd  International Conference on Human Papillomavirus, addressing the most recent advances across the spectrum of Genital research from basic sciences to public health, Conference Highlights will Human Papillomavirus, HPV in Men, Cancer and HPV, Cervical Cancer, HIV – Human Immunodeficiency Virus, Genital Herpes, Syphilis, Hepatitis B, Chlamydia Infection, Gonorrhoea, Chancroid, Pelvic Inflammatory Disease, Other Genital Infections, Vaccines and Vaccination, Public Awareness

TRACK 1: Human Papillomavirus

Virology of Human Papillomavirus  is a double-stranded DNA, non-enveloped capsid virus. Their genome has three functional coding regions. Genome organization is similar for all papillomaviruses which has one strand transcribed. Epidemiology of HPV Infection causes warts, which are noncancerous skin growths known as cutaneous warts. Organization of life cycle can be divided into discrete phases. Initial infection requires access of infectious particles to cells in the basal layer, which for some HPV types is thought to require a break in the stratified epithelium. Toxicity and pathogenesis, Infection by specific HPV types has been linked to the development of cervical carcinoma. HPV infects epithelial cells that undergo terminal differentiation and so encode multiple mechanisms to override the normal regulation of differentiation to produce progeny virions.  The mechanism of HPV  is very complicated as it infects basal epithelial cells, which constitute the onlt cell layer in an epithelium that is actively dividing. The estimated global HPV prevalence was found to be higher rates in sub-Saharan Africa (24%), Eastern Europe (21%) and Latin America (16%).

TRACK 2: HIV (Human Immunodeficiency Virus).

HIV gradually attacks the immune system after an infection, after which the immunity is weakened, the virus destroys T-helper cell and replicates. Although, there are various strains of HIV, the major 2 types of strains that infect majority of population are

•           HIV-1: the most common type found worldwide

•           HIV-2: this is found mainly in Western Africa, with some cases in India and Europe.

HIV infection leads to AIDS, after a person’s immune system is too fragile, to fight off many infections, and develops when the HIV infection is very advanced. This is the last stage of HIV infection where the body can no longer defend itself and may develop various diseases, infections and if left untreated, death.

HIV is primarily transmission through body fluids, viz., blood (via transfusion), semen, vaginal and rectal secretions (through sex), and breast milk (lactating mothers to babies).

TRACK 3: Hepatitis 

Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. The virus is transmitted through contact with the blood or other body fluids of an infected person. Hepatitis B is most commonly spread from mother to child at birth or through horizontal transmission by exposure to infected blood and various body fluids, as well as through saliva, menstrual, vaginal, and seminal fluids. Sexual transmission occurs, particularly in unvaccinated men or in heterosexual persons with multiple sex partners. Infection in adulthood leads to chronic hepatitis in less than 5% of cases. In addition, infection can occur during medical, surgical, dental procedures, tattooing, or through the use of razors and similar objects that can be contaminated with infected blood.

TRACK 4: Genital Herpes

Genital herpes is one of the major sexually transmitted infections, caused by the herpes simplex virus and affects the skin or mucous membranes of the genitals.

There are 2 types of herpes simplex virus (HSV):

•  HSV-1 most often affects the mouth and lips and causes cold sores or fever blisters and can spread from the mouth to the genitals during oral sex.

•  HSV type 2 (HSV-2) most often cause genital herpes and spreads through skin contact or through fluids from the mouth or genitals.

One can be infected with herpes if skin, vagina, penis, or mouth comes into contact with these parts of the infected individual. Genital HSV-2 infections are most commonly seen in women than men. General symptoms includes, Decreased appetite, Fever, malaise, Muscle aches, swollen and tender lymph nodes in the groin,  small, painful blisters  with clear or straw-coloured fluid in the labia, vagina, cervix, around the anus, and on the thighs or buttocks, Penis, scrotum, Tongue, mouth, eyes, gums, lips, fingers, and other parts of the body.

TRACK 5: Chlamydia Infections

Chlamydia is the most common sexually transmitted infection (STI) caused by bacteria, contracted generally while having unprotected sex with someone whose STI status is uncertain. The treatment for chlamydia is single or multiple doses of oral antibiotics. Unprotected sex is the main route a chlamydia infection is spread. New-born babies can acquire chlamydia from their infected mother during birth. Most of the times, the symptoms go unnoticed. Some of the most common symptoms include burning sensation during urination, yellowish-green discharge from the penis or vagina, pain in the lower abdomen, pain in the testicles, painful sexual intercourse in women.

TRACK 6: Gonorrhoea

Gonorrhoea is a STI caused by Neisseria gonorrhoea. And the bacteria are mainly found in the discharge of the penis and vaginal fluid. Gonorrhoea is easily passed between people through unprotected sex or by sharing vibrators or other sex toys that haven't been washed and covered with a new condom each time they're used. The bacteria infect the cervix, urethra, rectum, and is passed from a pregnant woman to her baby. Gonorrhoea isn't spread by hugging, kissing, sharing baths, sharing cutlery, swimming pools, and toilet seats or by sharing towels as the bacteria can’t survive for long outside the body.

TRACK 7: Syphilis

Syphilis is a sexually transmitted disease (STD) that has very serious complications when left untreated, and the symptoms are divided into 3 stages - primary, secondary, latent, and late syphilis. You can get syphilis by direct contact with syphilis sore during sex. Syphilis can also be spread from an infected mother to her unborn baby. Symptoms of syphilis can be confused by symptoms of other STDs, as it has many possible symptoms. The painless syphilis sore can be confused for an ingrown hair, zipper cut, or other seemingly harmless bump. The non-itchy body rash that develops during the second stage of syphilis can show up on the palms of your hands and soles of your feet, or sometimes all over your body. Syphilis can also affect the eye and can lead to permanent blindness. This is called ocular syphilis. You could also be infected with syphilis and have very mild symptoms or none at all.

TRACK 8: Pelvic Inflamatory Disease

Untreated sexually transmitted diseases can cause pelvic inflammatory disease (PID), which is a serious reproduction organ condition, in women. According to statistics, 1 in 8 women with a history of PID experience difficulties getting pregnant. One is likely to get PID, if they have an STD and do not get treated, or have multiple sex partners, or use an intrauterine device (IUD) for birth control methods. One should get examined immediately when experiencing pain in lower abdomen, have fever, or an malodorous unusual discharge from vagina, painful or bleeding intercourse, burning sensation while urinating, bleeding or spotting between periods.

TRACK 10: Chancroid

The bacterium Haemophilus ducreyi , attacks a tissue and produces an open sore, referred to as a chancroid or ulcer near to the external reproductive organs. The ulcer could bleed or produce a contagious fluid that can spread bacteria during intercourse or may also spread from skin-to-skin contact with an infected person. It’s a type of venereal disease- which is transmitted through sexual contact.

Symptoms include- varied sizes of painful ulcers, having a soft centre with grey to yellowish colour and defined, or sharp, edges which bleed easily when touched or during sexual intercourse Swelling in the groin and swollen lymph nodes that can break through the skin and oozes pus.

TRACK 11: Other Genital Infections

Molluscum contagiosum is a skin infection caused by Molluscum contagiosum virus and produces benign raised lesions, or bumps, on the upper layers of the skin and is spread through direct contact with the lesion of an infected person or by contact with a contaminated object, such as a towel or any other piece of clothing.

NGU (nongonococcal urethritis) is an infection of the urethra caused by microbes other than gonorrhoea; these microbes include, Chlamydia trachomatis, Ureaplasma urealyticum, Trichomonas vaginalis, Herpes simplex virus, Adenovirus, Haemophilus vaginalis, Mycoplasm genitalium. NGU can be transmitted by sexual, non-sexual and perinatal methods.

Trichomoniasis is a very common STD, caused by Trichomonas vaginalis. After an infection with the parasite, the symptoms may or may not develop with about 70% of infected people having no signs or symptoms. Although, if they can range from mild they do show symptoms, it ranges to severe inflammation, men may feel itching or irritation inside the penis, burning after /ejaculation, or some other discharge from the penis, while women may have itching, burning, redness or soreness of the genitals, discomfort with urination, or a clear, white, yellowish-greenish fluid discharge with bad odour.

Mucopurulent Cervicitis (MPC) is an STI of the cervix and is often, a result of chlamydia and gonorrhoea. Symptoms include, vaginal discharge, bleeding between periods or after sex, abdominal pain and pain during or after vaginal sex.

Bacterial vaginosis (BV) is caused when a particular type of bacteria creates imbalance by either an increase in their number or by decrease. The exact cause is not yet known but it is linked to the imbalance of the pathogenic and non-pathogenic bacteria in the vagina. Symptoms include thin white or grey vaginal discharge with bad odour, pain and itching, or burning in the vagina.

TRACK 12: Vaccines and Vaccination:

Vaccines contain a attenuated, killed or weakened pathogenic microbe, that causes the disease. A vaccine stimulates your immune system to produce antibodies, to develop immunity to that disease without getting infected. Although, both antibiotics and vaccines are used to fight germs, their mode of action is different- vaccines are used to prevent disease, while antibiotics are used to treat diseases. There are various types of vaccines, viz., Live, attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, DNA vaccines and recombinant vector vaccines.

TRACK 13: Public Awareness:

There are numerous foundations that work on the betterment on the society and help those suffering from STDs and STIs and other genital infections’ mentally and emotionally. These foundations help in creating awareness among masses especially the youngsters in the age-group of 16-30 years of age. These foundations help in the regular testing, counselling and treatment of the patients, helping them accept their condition and face the social stigma associated with the infections and discrimination.

Market analysis

Sexually Transmitted Diseases (STDs) are called venereal Diseases (VDs) or Sexually Transmitted Infections (STIs). A range of strategies have been utilized for the identification of STDs that disagree based on the kind of illness. The objective of this report is to produce AN in-depth understanding of diagnostic tests of STDs. Rising incidences of fatal STDs, corresponding high-economic burden and resultant implementation of Provider-Initiated guidance and Testing (PICT) and Client-Initiated content and Testing (CICT) drive the growth of STD testing market. Asia-Pacific market is growing at a major rate attributable to the causative factors such as massive cohort of the target population (aged 15–44 years) and consequently high testing volumes. Moreover, increasing antibiotic resistance that raises the prevalence and incidence rates and consequently the testing volumes in these regions propel the expansion of STDs testing market. Also, countries like Republic of India and China have high proportion or incidence of HIV infections. Sexually transmitted disease could be a common incidence as a co-infection with HIV, augmenting the growth of STDs testing market.

The Asia-Pacific market for diagnostic testing of STDs is segmental on the basis of type of STDs into chlamydia, gonorrhea, syphilis, Human immunodeficiency Virus (HIV), Herpes Simplex Virus (HSV), Human benign tumor Virus (HPV) and chancroid testing segments. Based on point of testing, market is segmental into laboratories and point-of-care (PoC). Currently, laboratories perform bulk of the tests and would continue to hold larger share of the market, both in terms of volume and revenue. PoCs will grow at a relentless rate during the forecast period. On the premise of testing devices, the market is chiefly segmental into laboratory devices and POC testing devices.

The Asia-Pacific STDs testing market is segmental into China, Japan, India, Australia and others. Emerging economies like Bharat, China, Singapore and Malaysia square measure the potential geographies for the market growth attributable to up health care standards. The prevalence and incidence rate for STDs are high in countries such as China and Asian nation attributable to high populations in these countries, driving the growth of STDs testing market. Key players in the STDs testing market square measure adopting strategies such as approval and acquisition, to make their presence in the market. The companies profiled in this market include Hologic Inc., Becton poet and Company, Cepheid INC., Affymetrix INC, Alere Inc., Abott Laboratories and few others.


• Extensive coverage of the Asia-Pacific sexually transmitted diseases (STDs) testing market including drivers, restraints and opportunities that would help professionals to better understand market behavior

•    Analyzing the present market trends, projections concerning the market potential for the period of 2014–2020 in terms useful area unit discussed

•    A comprehensive analysis of equipment types, applications, end users and geography segments allows the identification of growth opportunities at intervals the Asia-Pacific STDs testing market

•    Market attractiveness analysis for the Asia-Pacific STDs testing market provides strategic assistance to decision makers

• associate degree analysis of strategies utilized by key leaders within the Asia-Pacific STDs testing market would prove to be informative for professionals in the corporate sector

•    Porter’s five forces framework examines the competitive structure of Asia-Pacific STDs testing market and would be helpful for strategic industry analysis

• Ease of doing business analysis would help in making strategic business decisions


The Asia-Pacific sexually transmitted diseases (STDs) testing market is segmented into STDs’ type, location of testing, testing devices and geography segments.


•          Chlamydia testing

•          Syphilis testing

•          Gonorrhea testing

•          Herpes Simplex virus testing

•          Human papilloma virus testing

•          Human immunodeficiency virus testing

•          Chancroid testing


·         Laboratory testing

·         Commercial/private labs

·         Public health labs

·         Point-of-Care (PoC) testing


§  Laboratory devices: instruments and systems

§  Thermal cyclers – PCR

§  Lateral flow readers - immunochromatographic assays

§  Flow cytometers

§  Differential lightweight scattering machines

§  Absorbance micro plate reader - catalyst joined Immunosorbent Assay (ELISA)

§  POC testing devices: varied diagnostic kits

§  Phone chips (microfluidics + ICT)

§  Portable/bench top/rapid diagnostic kits

MARKET BY Geographic’s

·         China

·         Japan

·         India

·         Australia

·         Others

Past Conference Report

HPV 2016

Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date (10 Plenary Forums 2 days 1 Event)
November 13-14, 2017

For Sponsors & Exhibitors

Speaker Opportunity

Supported By

Journal of AIDS & Clinical Research Virology & Antiviral Research Journal of Genital System & Disorders Journal of Infectious Diseases & Therapy: open Access

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos

What People Say....

Thank you very much for giving me the opportunity of speaking about our research interest in your HPV meeting.


Kwang Poo Chang ,Chicago Medical School, USA

The conference was very enlightening especially in the international experts who presented.


Mary B. Prendergast, National University, USA